Tetrahydrobiopterin responsiveness of patients with phenylalanine hydroxylase deficiency;Responsividade à tetrahidrobiopterina em pacientes com deficiência de fenilalanina hidroxilase

Jornal de Pediatria

Volumn 87, Issue 3, 2011, Pages 245-251

  Giugliani, Luciana ^a   Sitta, Angela ^a   Vargas, Carmen R ^a   Santana da Silva, Luiz C ^a,b   Nalin, Tatiéle ^a   Saraiva Pereira, Maria Luiza ^a,c   Giugliani, Roberto ^a,d   Schwartz, Ida Vanessa D ^a,e  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Biopterin; Phenylalanine hydroxylase; Phenylketonuria

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TETRAHYDROBIOPTERIN;

ADOLESCENT; ARTICLE; BLOOD EXAMINATION; BRAZIL; CLINICAL ARTICLE; CONVENIENCE SAMPLE; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERPHENYLALANINEMIA; INTERVENTION STUDY; MALE; PHENYLKETONURIA; PROTEIN BLOOD LEVEL; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ANALYSIS OF VARIANCE; BIOPTERIN; FEMALE; HUMANS; MALE; PHENYLALANINE; PHENYLKETONURIAS; SEVERITY OF ILLNESS INDEX;

EID: 79958713407     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.2090     Document Type: Article

References (28)

1. Coelho JC, Wajner M, Burin MG, Vargas CR, Giugliani R. Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr. 1997;156:650-4. (Pubitemid 27351857)
2. Scriver C, Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 1667-724.
3. Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, et al. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr. 1999;135:375-8. (Pubitemid 30180515)
4. Fiege B, Bonafe L, Ballhausen D, Baumgartner M, Thony B, Meili D, et al. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol Genet Metab. 2005;86 Suppl 1:S91-5.
5. Levy HL, Milanowski A, Chakrapani A, Cleary M, Lee P, Trefz FK, et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet. 2007;370:504-10. (Pubitemid 47212372)
6. Michals-Matalon K. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8- tetrahydrobiopterin, in the treatment of phenylketonuria. Expert Opin Investig Drugs. 2008;17:245-51.
7. Trefz FK, Burton BK, Longo N, Casanova MM, Gruskin DJ, Dorenbaum A, et al. Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr. 2009;154:700-7.
8. Blau N, Belanger-Quintana A, Demirkol M, Feillet F, Giovannini M, MacDonald A, et al. Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria. Mol Genet Metab. 2009;96:158-63.
9. Zurfluh MR, Zschocke J, Lindner M, Feillet F, Chery C, Burlina A, Blau N, et al. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum Mutat. 2008;29:167-75.
10. Blau N, Erlandsen H. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab. 2004;82:101-11. (Pubitemid 38692547)
11. Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michiels L, et al. European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet. 1998;63:71-9. (Pubitemid 30428320)
12. Nalin T, Perry ID, Refosco LF, Netto CB, Souza CF, Schwartz IV, et al. Fenilcetonúria no sistema único de saúde: avaliação de adesão ao tratamento em um centro de atendimento do rio grande do sul. Rev HCPA. 2010;30:225-32.
13. Blau N. Defining tetrahydrobiopterin (BH4)-responsiveness in PKU. J Inherit Metab Dis. 2008;31:2-3.
14. BH4 Databases [Internet]. BIOPKU : International Database of Patients and Mutations causing BH4-responsive HPA/PKU; 2005. Disponível em: http://www.bh4.org/BH4DatabasesBiopku.asp. Acesso: 15/08/2008.
15. Ponzone A, Porta F, Mussa A, Alluto A, Ferraris S, Spada M. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency. Metabolism. 2010;59:645-52.
16. Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA, et al. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis. 2007;30:700-7. (Pubitemid 47559882)
17. Sanford M, Keating GM. Sapropterin: a review of its in the treatment of primary hyperphenylalaninaemia. Drugs. 2009;69:461-79.
18. Fiege B, Blau N. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria. J Pediatr. 2007;150:627-30. (Pubitemid 46755809)
19. Baldellou Vazquez A, Salazar Garcia-Blanco MI, Ruiz-Echarri Zalaya MP, Campos Calleja C, Ruiz Desviat L, Ugarte Perez M. Tetrahydrobiopterin therapy for hyperphenylalaninemia due to phenylalanine hydroxylase deficiency. When and how? An Pediatr (Barc). 2006;64:146-52.
20. Perez-Duenas B, Vilaseca MA, Mas A, Lambruschini N, Artuch R, Gomez L, et al. Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Clin Biochem. 2004;37:1083-90. (Pubitemid 39601096)
21. Boveda MD, Couce ML, Castineiras DE, Cocho JA, Perez B, Ugarte M, et al. The tetrahydrobiopterin loading test in 36 patients with hyperphenylalaninaemia: evaluation of response and subsequent treatment. J Inherit Metab Dis. 2007;30:812-5.
22. Belanger-Quintana A, Garcia MJ, Castro M, Desviat LR, Perez B, Mejia B, et al. Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin. Mol Genet Metab. 2005;86 Suppl 1:S61-6.
23. Hennermann JB, Buhrer C, Blau N, Vetter B, Monch E. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol Genet Metab. 2005;86 Suppl 1:S86-90.
24. Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, et al. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002;347:2122-32. (Pubitemid 36015124)
25. Levy H, Burton B, Cederbaum S, Scriver C. Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment. Mol Genet Metab. 2007;92:287-91. (Pubitemid 350117721)
26. Langenbeck U. Classifying tetrahydrobiopterin responsiveness in the hyperphenylalaninaemias. J Inherit Metab Dis. 2008;31:67-72.
27. Bernegger C, Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002. Mol Genet Metab. 2002;77:304-13.
28. Blau N, Belanger-Quintana A, Demirkol M, Feillet F, Giovannini M, Macdonald A, et al. Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab. 2010;99:109-15.